The genes that code for the transporters that are responsible for monoamine uptake were identified in the early 1990s. Monoamine transporters have been shown to be involved both in the regulation ...

The Mercury News reported on Monday that while raiding the home of a couple believed to have stolen $50,000-$60,000 worth of ...

Monoamine oxidase inhibitors (MAOIs) were the first medications approved for the treatment of depression symptoms and are also used to treat several other medical conditions, such as Parkinson's ...

Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and selectively inhibits monoamine oxidase type B (MAO-B). Rasagiline demonstrates complete and selective ...

Prasinezumab, an experimental monoclonal antibody treatment, may help reduce the deterioration of motor skills in people with ...

GlobalData is the parent company of Pharmaceutical Technology. Ingrezza is a selective and reversible inhibitor of the ...

More research is needed to better understand how antidepressants work and their efficacy, especially when taken over the ...

Each Ingrezza Sprinkle capsule contains oral granules consisting of valbenazine, a vesicular monoamine transporter 2 inhibitor. For patients who experience dysphagia or have difficulty swallowing, ...

Researchers reviewed 4 double-blind clinical trials to assess the results of patients treated with vesicular monoamine transporter 2 (VMAT2) inhibitors deutetrabenazine and valbenazine, which are ...

Busy is getting candid about navigating her ADHD diagnosis and treatment experience with Qelbree®The percentage of women newly diagnosed with ...

a MAO-B = monoamine oxidase type B, MAO-A = monoamine oxidase type A. b Expressed as the molar concentration of drug required to inhibit enzyme activity by 50% (nmol/L). c Expressed as the ...